Kanetake H - Search Results

1

Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of a randomized trial with epirubicin comparing short-term versus long-term maintenance treatment.

Nomata K, Noguchi M, Kanetake H, Tsuda N, Hayashi M, Yamashita S, Sakuragi T, Kusaba Y, Shindo K; Nagasaki Clinical Research Group for Bladder Cancer. Nomata K, et al. Among authors: kanetake h. Cancer Chemother Pharmacol. 2002 Oct;50(4):266-70. doi: 10.1007/s00280-002-0487-6. Epub 2002 Aug 24. Cancer Chemother Pharmacol. 2002. PMID: 12357299 Clinical Trial.

2

Renal cell carcinoma with solitary metachronous metastasis to the urinary bladder.

Matsuo M, Koga S, Nishikido M, Noguchi M, Sakaguchi M, Nomata K, Maruta N, Hayashi T, Kanetake H. Matsuo M, et al. Among authors: kanetake h. Urology. 2002 Nov;60(5):911-2. doi: 10.1016/s0090-4295(02)01900-3. Urology. 2002. PMID: 12429329 Review.

3

Long-term follow up of patients with invasive bladder carcinoma receiving combined cisplatin-based intra-arterial chemotherapy and radiotherapy.

Mori K, Nomata K, Noguchi M, Eguchi J, Hayashi N, Kanetake H. Mori K, et al. Among authors: kanetake h. Int J Urol. 2007 Jul;14(7):591-4. doi: 10.1111/j.1442-2042.2007.01780.x. Int J Urol. 2007. PMID: 17645599

4

The expression of platelet-derived endothelial cell growth factor in human bladder cancer.

Sawase K, Nomata K, Kanetake H, Saito Y. Sawase K, et al. Among authors: kanetake h. Cancer Lett. 1998 Aug 14;130(1-2):35-41. doi: 10.1016/s0304-3835(98)00097-4. Cancer Lett. 1998. PMID: 9751254

5

Angiogenin expression in superficial bladder cancer.

Maeda K, Nomata K, Noguchi M, Kanetake H. Maeda K, et al. Among authors: kanetake h. Hinyokika Kiyo. 2001 Aug;47(8):547-52. Hinyokika Kiyo. 2001. PMID: 11579593 Free article.

6

Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.

Miyata Y, Kanda S, Nomata K, Hayashida Y, Kanetake H. Miyata Y, et al. Among authors: kanetake h. Urology. 2004 Mar;63(3):602-8. doi: 10.1016/j.urology.2003.09.035. Urology. 2004. PMID: 15028476

7

Mucinous adenocarcinoma of the renal pelvis associated with transitional cell carcinoma in the renal pelvis and the bladder.

Takehara K, Nomata K, Eguchi J, Hisamatsu H, Maruta S, Hayashi T, Koga S, Kanetake H. Takehara K, et al. Among authors: kanetake h. Int J Urol. 2004 Nov;11(11):1016-8. doi: 10.1111/j.1442-2042.2004.00932.x. Int J Urol. 2004. PMID: 15509208 Free article.

8

Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract.

Miyata Y, Kanda S, Nomata K, Eguchi J, Kanetake H. Miyata Y, et al. Among authors: kanetake h. J Urol. 2005 Jan;173(1):56-60. doi: 10.1097/01.ju.0000148272.77539.2d. J Urol. 2005. PMID: 15592025

9

Pathological function of prostaglandin E2 receptors in transitional cell carcinoma of the upper urinary tract.

Miyata Y, Ohba K, Kanda S, Nomata K, Eguchi J, Hayashi T, Kanetake H. Miyata Y, et al. Among authors: kanetake h. Virchows Arch. 2006 Jun;448(6):822-9. doi: 10.1007/s00428-006-0198-1. Epub 2006 Apr 12. Virchows Arch. 2006. PMID: 16609907

10

Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis.

Miyata Y, Kanda S, Ohba K, Nomata K, Eguchi J, Hayashida Y, Kanetake H. Miyata Y, et al. Among authors: kanetake h. J Urol. 2006 Jul;176(1):348-53. doi: 10.1016/S0022-5347(06)00520-9. J Urol. 2006. PMID: 16753442

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters